Skip to main content

Eledon Pharmaceuticals, Inc.

ELDN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001404281

No open-market purchases or sales by Eledon Pharmaceuticals, Inc. insiders were filed in the last 90 days; 161 institutions reported holding it in 13F filings for Q2 2026, worth $184.6M in total; no superinvestor holds it.

13F holders, Q4 2021

Institutional positions in Eledon Pharmaceuticals, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
36
+1 vs. Q3 2021
Shares held
7.88M
−549.9K (−6.5%) vs. Q3 2021
Total value
$34.7M
−$17.4M (−33.3%) vs. Q3 2021
New holders
5
10 more added
Sold out
4
6 more reduced

Compare with Q3 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ELDN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2021: 36 institutions
Q1 2021: 34 institutionsQ2 2021: 34 institutionsQ3 2021: 35 institutionsQ4 2021: 36 institutionsQ1 2022: 32 institutionsQ2 2022: 31 institutionsQ3 2022: 31 institutionsQ4 2022: 28 institutionsQ1 2023: 30 institutionsQ2 2023: 33 institutionsQ3 2023: 28 institutionsQ4 2023: 29 institutionsQ1 2024: 29 institutionsQ2 2024: 32 institutionsQ3 2024: 33 institutionsQ4 2024: 75 institutionsQ1 2025: 83 institutionsQ2 2025: 85 institutionsQ3 2025: 83 institutionsQ4 2025: 95 institutionsQ1 2026: 121 institutionsQ2 2026: 161 institutions
Value heldQ4 2021: $34.7M
Q1 2021: $89.0MQ2 2021: $74.5MQ3 2021: $52.1MQ4 2021: $34.7MQ1 2022: $27.6MQ2 2022: $15.9MQ3 2022: $17.3MQ4 2022: $14.4MQ1 2023: $14.7MQ2 2023: $12.7MQ3 2023: $12.2MQ4 2023: $16.5MQ1 2024: $19.8MQ2 2024: $48.2MQ3 2024: $46.0MQ4 2024: $158.5MQ1 2025: $130.3MQ2 2025: $110.7MQ3 2025: $94.5MQ4 2025: $66.7MQ1 2026: $131.2MQ2 2026: $184.6M
Institutions holding ELDN and their total value by quarter
QuarterHoldersValue
Q2 2026161$184.6M
Q1 2026121$131.2M
Q4 202595$66.7M
Q3 202583$94.5M
Q2 202585$110.7M
Q1 202583$130.3M
Q4 202475$158.5M
Q3 202433$46.0M
Q2 202432$48.2M
Q1 202429$19.8M
Q4 202329$16.5M
Q3 202328$12.2M
Q2 202333$12.7M
Q1 202330$14.7M
Q4 202228$14.4M
Q3 202231$17.3M
Q2 202231$15.9M
Q1 202232$27.6M
Q4 202136$34.7M
Q3 202135$52.1M
Q2 202134$74.5M
Q1 202134$89.0M

Institutions, Q4 2021

Shares, value and share of portfolio for each institution holding Eledon Pharmaceuticals, Inc.; share changes are against Q3 2021.

Institutions holding ELDN in Q4 2021
InstitutionSharesValue% of portfolioChange in sharesAction
BVF Inc1,378,020$6.08M0.22%+14,585+1.1%Added
Logos Global Management LP1,339,793$5.91M0.61%00.0%Unchanged
Cormorant Asset Management, LP1,305,095$5.75M0.34%00.0%Unchanged
Woodline Partners LP781,376$3.45M0.05%00.0%Unchanged
Vanguard Group Inc669,700$2.95M0.00%−813−0.1%Reduced
FMR LLC504,371$2.22M0.00%−499,740−49.8%Reduced
Point72 Asset Management, L.P.431,435$1.90M0.01%+221,945+105.9%Added
Ikarian Capital, LLC344,578$1.52M0.43%00.0%Unchanged
Two Sigma Advisers, LP127,600$563.0K0.00%+11,700+10.1%Added
Geode Capital Management, LLC126,710$558.0K0.00%−848−0.7%Reduced
Two Sigma Investments, LP125,193$552.0K0.00%+9,869+8.6%Added
CM Management, LLC115,000$507.0K0.38%+40,000+53.3%Added
Eversept Partners, LP114,008$502.8K0.04%00.0%Unchanged
Ensign Peak Advisors, Inc77,100$340.0K0.00%+69,872+966.7%Added
BlackRock Inc.63,166$279.0K0.00%+15,658+33.0%Added
Ingalls & Snyder LLC51,149$226.0K0.01%00.0%Unchanged
Jmac Enterprises LLC54,538$216.0K0.05%+54,538New
State Street Corp40,435$178.0K0.00%00.0%Unchanged
Millennium Management LLC36,242$160.0K0.00%+25,693+243.6%Added
Boothbay Fund Management, LLC34,630$153.0K0.01%00.0%Unchanged
Veritable, L.P.33,092$146.0K0.00%00.0%Unchanged
Northern Trust Corp30,053$133.0K0.00%00.0%Unchanged
Ameritas Advisory Services, LLC24,219$107.0K0.00%+24,219New
Mercer Global Advisors Inc16,726$74.0K0.00%00.0%Unchanged
Envestnet Asset Management Inc16,726$74.0K0.00%00.0%Unchanged
Renaissance Technologies LLC13,673$60.0K0.00%−25,990−65.5%Reduced
Citadel Advisors LLC10,174$45.0K0.00%+10,174New
Morgan Stanley8,771$39.0K0.00%−100,685−92.0%Reduced
UBS Group AG3,638$16.0K0.00%+3,583+6,514.5%Added
Simplex Trading, LLC2,717$11.0K0.00%+2,682+7,662.9%Added
Tower Research Capital LLC (TRC)2,056$9.00K0.00%+2,056New
Rockefeller Capital Management L.P.1,666$7.00K0.00%00.0%Unchanged
Spire Wealth Management850$4.00K0.00%00.0%Unchanged
Federated Hermes, Inc.211$1.00K0.00%+211New
Bank of America Corp27$00.00%−184−87.2%Reduced
Wells Fargo & Company88$00.00%00.0%Unchanged
Adage Capital Partners GP, L.L.C.0$00.00%−409,759−100.0%Sold out
Virtu Financial LLC0$00.00%−18,610−100.0%Sold out
JPMorgan Chase & Co0$00.00%−20−100.0%Sold out
Jacobi Capital Management LLC0$00.00%−3−100.0%Sold out